These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 6594762)

  • 1. Cardiac effects of anthracyclines used in the treatment of childhood acute lymphoblastic leukemia: a 10-year experience.
    Sallan SE; Clavell LA
    Semin Oncol; 1984 Dec; 11(4 Suppl 3):19-21. PubMed ID: 6594762
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase II study of idarubicin administered i.v. to pediatric patients with acute lymphoblastic leukemia.
    Madon E; Grazia G; De Bernardi B; Comelli A; Carli M; Sainati L; Paolucci G; Canino R; Colella R; Bagnulo S
    Cancer Treat Rep; 1987 Sep; 71(9):855-6. PubMed ID: 3476202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac functions by myocardial performance index and QT dispersion in survivors of childhood lymphoblastic leukaemia.
    Gulen H; Kazanci E; Mese T; Uzunkaya D; Erbay A; Tavli V; Vergin C
    Minerva Pediatr; 2007 Apr; 59(2):107-13. PubMed ID: 17404560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Daunorubicin (NSC 82151) in the treatment of advanced childhood lymphoblastic leukemia.
    Jones B; Holland JF; Morrison AR; Lee SL; Sinks LF; Cuttner J; Rausen A; Kung F; Pluss HJ; Haurani FI; Patterson RB; Blom J; Burgert EO; Moon JH; Chevalier L; Sawitsky A; Albala MM; Forcier RJ; Falkson G; Glidewell O
    Cancer Res; 1971 Feb; 31(2):84-90. PubMed ID: 5278102
    [No Abstract]   [Full Text] [Related]  

  • 5. Late cardiotoxicity of anthracyclines in children with acute leukemia.
    Zalewska-Szewczyk B; Lipiec J; Bodalski J
    Klin Padiatr; 1999; 211(4):356-9. PubMed ID: 10472576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cardiotoxicity of anthracyclines. Apropos of 12 pediatric cases].
    Favrot MC; Pouyau G; Souillet G; Philip T; Bozzio A; Philippe N
    Pediatrie; 1981 Sep; 36(6):437-50. PubMed ID: 6947199
    [No Abstract]   [Full Text] [Related]  

  • 7. Time relationship between last dose of daunorubicin and congestive heart failure.
    Von Hoff DD; Layard M; Rozencweig M; Muggia FM
    Cancer Treat Rep; 1977 Oct; 61(7):1411-3. PubMed ID: 271046
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies with anthracyclines in pediatric acute nonlymphocytic leukemia.
    Chard RL
    Cancer Treat Rep; 1981; 65 Suppl 4():77-81. PubMed ID: 6179617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cardiotoxicity of daunorubicin and aclacinomycin A in patients with acute leukemia].
    Haruyama H; Shimazaki C; Nakanishi S; Hamami T; Nisio A; Isemura T; Katsume H; Nakagawa M; Ijichi H
    Gan To Kagaku Ryoho; 1982 Mar; 9(3):516-21. PubMed ID: 6964037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aclacinomycin A: clinical development of a novel anthracycline antibiotic in the haematological cancers.
    Warrell RP
    Drugs Exp Clin Res; 1986; 12(1-3):275-82. PubMed ID: 3525076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late cardiac effects of anthracycline containing therapy for childhood acute lymphoblastic leukemia.
    Rathe M; Carlsen NL; Oxhøj H
    Pediatr Blood Cancer; 2007 Jun; 48(7):663-7. PubMed ID: 17405151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cardiotoxic effect of anthracycline antibiotics].
    Jovanović I; Ceranić LJ; Simeunović S; Cvetković P
    Bilt Hematol Transfuz; 1983; 11(2-3):51-7. PubMed ID: 6680300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exposure to anthracyclines during childhood causes cardiac injury.
    Lipshultz SE
    Semin Oncol; 2006 Jun; 33(3 Suppl 8):S8-14. PubMed ID: 16781284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proceedings: Daunorubicin cardiac toxicity in children with acute lymphocytic leukemia.
    Halazun JF; Wagner HR; Gaeta JF; Sinks LF
    Cancer; 1974 Feb; 33(2):545-54. PubMed ID: 4521474
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cardiac insufficiency caused by the use of daunorubicin. Clinical and developmental study of 4 recent cases].
    Bauters F; Plouvier B; Breviere G; Goudemand M
    Sem Hop; 1975 Jun; 51(28):1949-57. PubMed ID: 180611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Echocardiographic evaluation in pediatric patients treated with anthracyclines].
    Accornero M; Ramenghi U; Amadio F; Barattia G; Ciriotti G; Saracco P; Tabasso PM; Grazia G
    Minerva Pediatr; 1985 Sep; 37(18):671-7. PubMed ID: 3866139
    [No Abstract]   [Full Text] [Related]  

  • 17. Anthracyclines in the treatment of acute nonlymphocytic leukemias.
    Boiron M; Jacquillat C; Marty M; Weil M; Gisselbrecht C
    Cancer Treat Rep; 1981; 65 Suppl 4():73-6. PubMed ID: 6955013
    [No Abstract]   [Full Text] [Related]  

  • 18. [Studies on the cardiotoxicity of daunomycin in patients with acute leukemia].
    Marni E; Marchi A; Laini C; Zanol MG; Martini A; Livieri C; Genova R
    Minerva Pediatr; 1978 Feb; 30(4):333-8. PubMed ID: 273716
    [No Abstract]   [Full Text] [Related]  

  • 19. [Acute heart failure after a moderate dose of rubidomycin].
    Baledent M; Messerschmitt J; Bens JL; Quiret JC; Faille N
    Sem Hop; 1972 Feb; 48(7):507-10. PubMed ID: 4338408
    [No Abstract]   [Full Text] [Related]  

  • 20. [The effect of cytostatic therapy on hemodynamics (author's transl)].
    Schwingshackl H; Schwingshackl A; Dienstl F; Knapp E; Gmeiner R
    Med Klin; 1974 Feb; 69(7):298-303. PubMed ID: 4522909
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.